ASTM E2363-23 PDF
Standard Terminology Relating to Manufacturing of Pharmaceutical and Biopharmaceutical Products in the Pharmaceutical and Biopharmaceutical Industry
Standard Terminology Relating to Manufacturing of Pharmaceutical and Biopharmaceutical Products in the Pharmaceutical and Biopharmaceutical Industry
- Статус документа:
- Действующий
- Формат:
- Электронный (PDF)
- Количество страниц:
- 16
- Дата публикации:
- 1 января 2023 г.
- Издание:
- E2363
- ICS:
- 01.040.11
SCOPE 1.1 This standard covers terminology used by the E55 Committee relating to pharmaceutical and biopharmaceutical industry for manufacture of pharmaceutical and biopharmaceutical products. Terms that are generally understood and in common usage or adequately defined in other readily available references are not included except where particular delineation to pharmaceutical and biopharmaceutical manufacturing may be more clearly stated. 1.2 This terminology is, therefore, intended to be selective of terms used generally in the manufacture of pharmaceutical and biopharmaceutical products and published in a number of documents such as those listed in the succeeding section. The listing is also intended to define terms that appear prominently within other related ASTM International standards and do not appear elsewhere. 1.3 The definitions are substantially identical to those published by regulatory agencies such as the U.S. Food and Drug Administration, European Medicines Agency, Pharmaceutical and Medical Devices Agency (Japan), other and national competent authorities (human) as well as other authoritative bodies, such as ICH, ISO, and national standards organizations. 1.4 This terminology supplements current documents on terminology that concentrate on the manufacture of pharmaceutical and biopharmaceutical products. 1.5 An increasing number of product designations and designations for chemical, physical, mechanical, analytical, and statistical tests and standards are coming into common usage in the literature, regulatory environment, and commerce associated with the manufacture of pharmaceutical and biopharmaceutical products. 1.6 Units—The values stated in SI units are to be regarded as the standard. No other units of measurement are included in this standard. 1.7 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use. 1.8 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
Abstract
Overview
ASTM E2363-23: Standard Terminology Relating to Manufacturing of Pharmaceutical and Biopharmaceutical Products in the Pharmaceutical and Biopharmaceutical Industry is a crucial reference developed by ASTM International for professionals working within the pharmaceutical and biopharmaceutical sector. This standard, managed by ASTM Committee E55, establishes a comprehensive and harmonized set of terminology specific to the manufacture of pharmaceutical and biopharmaceutical products, addressing a significant need for consistent language across organizations, regulatory bodies, and documentation.
ASTM E2363-23 is particularly valuable as it brings together commonly used and regulatory agency-approved definitions, supporting alignment with agencies including the FDA, EMA, PMDA, ICH, ISO, and various national standards organizations. The document selectively includes terms not already adequately defined elsewhere, ensuring clarity and relevance to current manufacturing practices.
Key Topics
The scope of ASTM E2363-23 addresses:
- Terminology Standardization: Providing precise definitions of terms as applied in pharmaceutical and biopharmaceutical manufacturing, including analytical procedures, process parameters, risk management, and quality systems.
- Process Analytical Technology (PAT): Defining terms relevant to the PAT framework, which is central to modern, real-time process monitoring and control in manufacturing.
- Manufacturing Concepts: Clarifying key terms such as batch, lot, control strategy, process validation, in-process control, and manufacturing systems, supporting process efficiency and compliance.
- Regulatory Consistency: Harmonizing terminology with major regulatory documents (FDA, ICH, ISO, etc.), facilitating international compatibility and compliance.
- Test and Measurement: Addressing terms for chemical, physical, mechanical, analytical, and statistical tests crucial to product quality and validation.
- Safety and Risk Management: Including widely recognized definitions for elements such as CGMP (current Good Manufacturing Practices), risk management, quality systems, and process controls.
Applications
The practical applications of ASTM E2363-23 include:
- Manufacturing Documentation: Ensuring that internal and external documents-such as SOPs, training manuals, and batch records-use standardized, universally understood terms.
- Regulatory Submissions: Facilitating the preparation of submissions to regulatory authorities by referencing harmonized terminology, thereby reducing the risk of misinterpretation.
- Quality Management Systems: Supporting the consistent implementation of quality control, risk management, and process validation practices in line with international norms.
- Process Development and Technology Transfer: Streamlining communication during process scale-up, technology transfer, and cross-functional collaboration by utilizing consistent terminology.
- Workforce Training: Assisting with the training and onboarding of employees by providing clear, unambiguous definitions for key concepts and procedures.
- Audit and Compliance: Enhancing the robustness of audits and inspections by ensuring all parties share a common understanding of essential manufacturing and quality terms.
Related Standards
ASTM E2363-23 references and is complemented by several notable standards and regulatory guides, including:
- ASTM E2500: Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment
- ASTM E2629: Guide for Verification of Process Analytical Technology (PAT)-Enabled Control Systems
- ISO 9000: Quality Management Systems-Fundamentals and Vocabulary
- ICH Q7, Q8, Q9, Q10, Q11: Comprehensive international guidelines for pharmaceutical development, quality risk management, and GMP for APIs
- 21 CFR 210 and 314: U.S. FDA regulations defining Good Manufacturing Practice and drug approval terminologies
- EU GMP Glossary: Terms used in European Good Manufacturing Practice
By aligning with ASTM E2363-23, organizations in the pharmaceutical and biopharmaceutical industry can ensure clarity, consistency, and regulatory compliance across global operations.
Keywords: ASTM E2363-23, pharmaceutical manufacturing terminology, biopharmaceutical terminology, process analytical technology, GMP, quality systems, regulatory standards, PAT, pharmaceutical industry, biopharmaceutical products, manufacturing process, compliance.
Технические детали
- Технический комитет
- E55 - Manufacture of Pharmaceutical and Biopharmaceutical Products
- SKU
- ASTM E2363-23
Похожие стандарты
Упомянутые в описании и другие стандарты ASTM
SIST EN ISO 9000:2015
ДействующийQuality management systems - Fundamentals and vocabulary (ISO 9000:2015)
Overview EN ISO 9000:2015 (ISO 9000:2015) - Quality management systems - Fundamentals and vocabulary - establishes the foundational concepts, quality management principles and the standardized vocabu…
ASTM-TPT-47
Phase I & Phase II Environmental Site Assessment Processes
Phase I & Phase II Environmental Site Assessment Processes
ASTM-TPT-8
Phase I Environmental Site Assessment Practices For Commercial Real Estate: Phase I Site Assessment & Transac…
ASTM-TPT-1137
ASTM D975 Standard Specification for Diesel Fuel
ASTM D975 Standard Specification for Diesel Fuel
ASTM-TPT-1202
ASTM D8421 Standard Test Method for Determination of Per- and Polyfluoroalkyl Substances (PFAS) in Aqueous Ma…
ASTM D8421 Standard Test Method -- eLearning Course
ASTM-TPT-691
Microaprendizagem para D4057: Amostragem de ponto (PT)
D4057 Microlearning: Spot Sampling Portuguese
ASTM-TPT-1091
Metodo de prueba estandar D4052 de ASTM -- Curso de aprendizaje electrónico (ES)
Modulo eLearning para ASTM D4052 en espanol
ASTM ACEM20180086
Using Neutron Radiography to Quantify the Settlement of Fresh Concrete
Specifications have been implemented for concrete bridge decks in North America that restrict the use of higher slump concrete mixtures primarily because of concerns about differential settlement and…